Cargando…

The Association Between Cytomegalovirus Infection and Cardiac Allograft Vasculopathy in the Era of Antiviral Valganciclovir Prophylaxis

Previous studies on the association between cytomegalovirus (CMV) infection and cardiac allograft vasculopathy (CAV) were conducted on patients transplanted in the prevalganciclovir prophylaxis era. The aim of our study is to evaluate this relation in heart transplantation (HTx) recipients treated a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klimczak-Tomaniak, Dominika, Roest, Stefan, Brugts, Jasper J., Caliskan, Kadir, Kardys, Isabella, Zijlstra, Felix, Constantinescu, Alina A., Voermans, Jolanda J.C., van Kampen, Jeroen J.A., Manintveld, Olivier C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Original Clinical Science—General
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306257/ https://www.ncbi.nlm.nih.gov/pubmed/31644496 http://dx.doi.org/10.1097/TP.0000000000003015

Ejemplares similares

Incidence of end‐stage renal disease after heart transplantation and effect of its treatment on survival
por: Roest, Stefan, et al.
Publicado: (2020)

Cardiac allograft vasculopathy and donor age affecting permanent pacemaker implantation after heart transplantation
por: Roest, Stefan, et al.
Publicado: (2022)

Epicardial fat volume is related to the degree of cardiac allograft vasculopathy
por: Roest, Stefan, et al.
Publicado: (2022)

Clinical implementation of coronary computed tomography angiography for routine detection of cardiac allograft vasculopathy in heart transplant patients
por: Nous, Fay M. A., et al.
Publicado: (2021)

Cardiac allograft vasculopathy in Dutch heart transplant recipients
por: Galli, G., et al.
Publicado: (2016)

Theophylline Use to Prevent Permanent Pacing in the Contemporary Era of Heart Transplantation: The Rotterdam Experience
por: Kooij, Claudette, et al.
Publicado: (2022)

COVID-19-related myocarditis post-heart transplantation
por: Roest, Stefan, et al.
Publicado: (2021)

Influence of renal insufficiency pre‐heart transplantation on malignancy risk post‐heart transplantation
por: Roest, Stefan, et al.
Publicado: (2021)

Aortic root thrombus after left ventricular assist device implantation and aortic valve replacement
por: Veenis, Jesse F., et al.
Publicado: (2020)

Cytomegalovirus retinitis treated with valganciclovir in Wegener’s granulomatosis
por: Kabata, Yoshiaki, et al.
Publicado: (2012)

Temporal patterns of macrophage‐ and neutrophil‐related markers are associated with clinical outcome in heart failure patients
por: Klimczak‐Tomaniak, Dominika, et al.
Publicado: (2020)

Valganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients
por: Patil, A Jayaprakash, et al.
Publicado: (2010)

Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients
por: Doesch, Andreas O, et al.
Publicado: (2012)

Dynamic personalized risk prediction in chronic heart failure patients: a longitudinal, clinical investigation of 92 biomarkers (Bio-SHiFT study)
por: Klimczak-Tomaniak, Dominika, et al.
Publicado: (2022)

High frequency of valganciclovir underdosing for cytomegalovirus prophylaxis after renal transplantation
por: Rissling, Olesja, et al.
Publicado: (2018)

1146. Thrombocytosis in Infants with Congenital Cytomegalovirus Infection Being Treated with Valganciclovir
por: Murtagh, Kathleen, et al.
Publicado: (2020)

Transhepatic echocardiography: a novel approach for imaging in left ventricle assist device patients with difficult acoustic windows
por: Strachinaru, Mihai, et al.
Publicado: (2020)

Survival following a concomitant aortic valve procedure during left ventricular assist device surgery: an ISHLT Mechanically Assisted Circulatory Support (IMACS) Registry analysis
por: Veenis, Jesse F., et al.
Publicado: (2020)

Safety and feasibility of hemodynamic pulmonary artery pressure monitoring using the CardioMEMS device in LVAD management
por: Veenis, Jesse F., et al.
Publicado: (2021)

Preventing LVAD implantation by early short-term mechanical support and prolonged inodilator therapy: A case series with acute refractory cardiogenic shock treated with veno-arterial extracorporeal membrane oxygenation and optimised medical strategy
por: Brugts, J. J., et al.
Publicado: (2014)

Efficacy of Extended Valganciclovir Prophylaxis in Preventing Cytomegalovirus Infection in Pediatric Kidney Transplantation
por: Hashim, Faris, et al.
Publicado: (2014)

Assessment of mitochondrial toxicity in newborns and infants with congenital cytomegalovirus infection treated with valganciclovir
por: Ortiz-Gracia, Alba, et al.
Publicado: (2022)

Preoperative right heart hemodynamics predict postoperative acute kidney injury after heart transplantation
por: Guven, Goksel, et al.
Publicado: (2018)

Evaluation of patients with a HeartMate 3 left ventricular assist device using echocardiographic particle image velocimetry
por: Schinkel, Arend F. L., et al.
Publicado: (2020)

Circulating and Platelet MicroRNAs in Cardiovascular Risk Assessment and Antiplatelet Therapy Monitoring
por: Procyk, Grzegorz, et al.
Publicado: (2022)

Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial
por: Reischig, Tomas, et al.
Publicado: (2018)

Correlation of cytomegalovirus viral load between whole blood and plasma of congenital cytomegalovirus infection under valganciclovir treatment
por: Torii, Yuka, et al.
Publicado: (2023)

Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis
por: Vaziri, Siavash, et al.
Publicado: (2014)

Single-Center Experience With Protocolized Treatment of Left Ventricular Assist Device Infections
por: Verkaik, Nelianne J., et al.
Publicado: (2022)

Monitoring pulmonary pressures during long‐term continuous‐flow left ventricular assist device and fixed pulmonary hypertension: redefining alleged pathophysiological mechanisms?
por: De Bakker, Chantal C., et al.
Publicado: (2020)

(18)F-FDG PET/CT in the Diagnosis and Management of Continuous Flow Left Ventricular Assist Device Infections: A Case Series and Review of the Literature
por: Akin, Sakir, et al.
Publicado: (2018)

Risk factors of cardiac allograft vasculopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015)

Valganciclovir for Cytomegalovirus Prevention in Solid Organ Transplant Patients: An Evidence-Based Reassessment of Safety and Efficacy
por: Kalil, Andre C., et al.
Publicado: (2009)

Long-term results of oral valganciclovir for treatment of anterior segment inflammation secondary to cytomegalovirus infection
por: Wong, Victoria WY, et al.
Publicado: (2012)

Efficacy of Valganciclovir Treatment Depends on the Severity of Hearing Dysfunction in Symptomatic Infants with Congenital Cytomegalovirus Infection
por: Ohyama, Shohei, et al.
Publicado: (2019)

Early rapidly developing constrictive pericarditis after aortic valve surgery
por: Brugts, J. J., et al.
Publicado: (2014)

Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients
por: Johansson, Inger, et al.
Publicado: (2015)

Design and rationale of haemodynamic guidance with CardioMEMS in patients with a left ventricular assist device: the HEMO‐VAD pilot study
por: Veenis, Jesse F., et al.
Publicado: (2019)

Left ventricular remodelling and prognosis after discharge in new‐onset acute heart failure with reduced ejection fraction
por: van den Berge, Jan C., et al.
Publicado: (2021)

Emerging electromagnetic interferences between implantable cardioverter-defibrillators and left ventricular assist devices
por: Yalcin, Yunus C, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ko28raif1goeo7cohr8e9hntd8